These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7005167)

  • 1. [The influence of the drug legislation on drug information for the physician and patient].
    Schwabe U
    Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is drug therapy safer as a result of the drug legislation?].
    Kimbel KH
    Internist (Berl); 1980 Jun; 21(6):306-10. PubMed ID: 7005166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug safety through drug legislation].
    Kimbel KH
    Internist (Berl); 1978 Jun; 19(6):326-32. PubMed ID: 352981
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug effectiveness in the framework of drug legislation and health insurance law].
    Töns H
    Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171
    [No Abstract]   [Full Text] [Related]  

  • 7. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 8. [New order in drug legislation].
    Feiden K
    Dtsch Med Wochenschr; 1975 Apr; 100(17):972-6. PubMed ID: 1091438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development and testing of a pilot information system for pharmacotherapy on the basis of linked data banks of pharmaceutical products and biomedical literature].
    Rosenkranz KO; Unger GE
    Methods Inf Med Suppl; 1978; 11():425-39. PubMed ID: 279773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use observations. On what studies can the physician rely?].
    Dietlein G; Dobmeyer J
    MMW Fortschr Med; 2002 Feb; 144(8):35-7. PubMed ID: 11910821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences in approving drugs].
    Schnieders B
    Internist (Berl); 1980 Jun; 21(6):325-32. PubMed ID: 7005169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and limits of drug supervision].
    Homann G
    Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116
    [No Abstract]   [Full Text] [Related]  

  • 13. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
    Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A
    Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Education responsibility, specialty and administration information from the legal viewpoint].
    Schreiber HL
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):653-7. PubMed ID: 9527463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drug legislation. How does it concern the druggists?].
    Fink J
    ZFA (Stuttgart); 1980 Jan; 56(2):57-63. PubMed ID: 6989121
    [No Abstract]   [Full Text] [Related]  

  • 16. Rules set for dissemination of off-label-use information.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500
    [No Abstract]   [Full Text] [Related]  

  • 17. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patient education responsibility, specialty and administration information from the internal medicine viewpoint].
    Ludwig WD
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):657-61. PubMed ID: 9527464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patient education and specialty prescription information from the psychiatric viewpoint].
    Linden M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):662-7; discussion 667-8. PubMed ID: 9527465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic awareness of the patient].
    Weber E
    Internist (Berl); 1980 Jun; 21(6):318-24. PubMed ID: 7005168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.